CFT8919

Non-Small Cell Lung Carcinoma

Betta Pharmaceuticals Co., Ltd.Phase 1

—

Rating in progress

CFT8919 in Non-Small Cell Lung Carcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active